Chairs:
Dr. Miguel Ángel Sanz
Hospital Universitario y Politécnico La Fe. Valencia, Spain
Dr. Joaquín Sánchez
Reina Sofía, Córdoba, Spain
16:10 - 16:30Major altered signaling pathways in AML
Dr. Joaquín Sánchez
Hospital Reina Sofía, Córdoba, Spain
16:30 - 16:50MRD assessment and follow up
Dr. Konstanze Döhner
Universitätsklinikum Ulm, Germany
16:50 - 17:10Impact of coexisting mutations and mechanisms of resistance to new agents
Dr. Mª José Calasanz
CIMA LAB Diagnostics UNAV, Pamplona, Spain
17:10 - 17:25Discussion
Chairs:
Dr. Guillermo García-Manero
MD Anderson Cancer Center, Houston, USA
Dr. Adolfo de la Fuente
MD Anderson Cancer Center Madrid, Spain
17:40 - 18:00Prognostic and management of myelofibrosis patients who fail conventional treatment
Dr. Valentín García Gutiérrez
Hospital Universitario Ramón y Cajal, Madrid, Spain
18:00 - 18:20Management of lower risk MDS
Dr. María Díez Campelo
Hospital Clínico Universitario de Salamanca, Spain
18:20 - 18:40CMML management
Dr. Breno Gusmão
Hospital Beneficência Portuguesa, São Paulo, Brasil
18:40 - 19:00Oral therapies in MDS
Dr. Guillermo García-Manero
MD Anderson Cancer Center, Houston, USA
19:00 - 19:15Discussion